EQL Pharma AB (publ) (STO:EQL)
91.20
-0.60 (-0.65%)
At close: Jun 26, 2025
EQL Pharma AB Market Cap
EQL Pharma AB has a market cap or net worth of 2.62 billion as of June 27, 2025. Its market cap has increased by 77.17% in one year.
Market Cap
2.62B
Enterprise Value
2.98B
Revenue
373.52M
Ranking
n/a
PE Ratio
62.50
Stock Price
91.20
Market Cap Chart
Since December 17, 2013, EQL Pharma AB's market cap has increased from 78.22M to 2.62B, an increase of 3,243.96%. That is a compound annual growth rate of 35.57%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Swedish Orphan Biovitrum AB | 95.21B |
Sectra AB | 64.93B |
Getinge AB | 50.58B |
Asker Healthcare Group AB | 40.96B |
Medicover AB | 35.78B |
Camurus AB | 34.88B |
AddLife AB | 22.31B |
Vimian Group AB | 21.09B |